Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2020

Jul 17, 2020

BUY
$111.92 - $142.53 $212,648 - $270,807
1,900 Added 9.18%
22,600 $18,000
Q1 2020

Apr 21, 2020

BUY
$92.66 - $144.94 $111,192 - $173,928
1,200 Added 6.15%
20,700 $99,000
Q4 2019

Feb 12, 2020

BUY
$116.25 - $133.25 $116,250 - $133,250
1,000 Added 5.41%
19,500 $70,000
Q3 2019

Nov 07, 2019

SELL
$112.57 - $128.43 $1.09 Million - $1.25 Million
-9,700 Reduced 34.4%
18,500 $43,000
Q1 2019

May 06, 2019

BUY
$81.56 - $100.67 $65,248 - $80,536
800 Added 2.92%
28,200 $178,000
Q4 2018

Feb 11, 2019

SELL
$79.28 - $95.27 $55,496 - $66,689
-700 Reduced 2.49%
27,400 $4,000
Q3 2018

Nov 14, 2018

BUY
$83.5 - $93.23 $592,850 - $661,933
7,100 Added 33.81%
28,100 $38,000
Q1 2018

Apr 16, 2018

BUY
$71.51 - $84.69 $1.5 Million - $1.78 Million
21,000 New
21,000 $21,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.